Delayed Flumazenil Injection after Endoscopic Sedation Increases Patient Satisfaction Compared with Immediate Flumazenil Injection

نویسندگان

  • Hyun Jung Chung
  • Byoung Wook Bang
  • Hyung Gil Kim
  • Kye Sook Kwon
  • Yong Woon Shin
  • Seok Jeong
  • Don Haeng Lee
  • Shin Goo Park
چکیده

BACKGROUND/AIMS Flumazenil was administered after the completion of endoscopy under sedation to reduce recovery time and increase patient safety. We evaluated patient satisfaction after endoscopy under sedation according to the timing of a postprocedural flumazenil injection. METHODS In total, 200 subjects undergoing concurrent colonoscopy and upper endoscopy while sedated with midazolam and meperidine were enrolled in our investigation. We randomly administered 0.3 mg of flumazenil either immediately or 15 minutes after the endoscopic procedure. A postprocedural questionnaire and next day telephone interview were conducted to assess patient satisfaction. RESULTS Flumazenil injection timing did not affect the time spent in the recovery room when comparing the two groups of patients. However, the subjects in the 15 minutes injection group were more satisfied with undergoing endoscopy under sedation than the patients in the immediate injection group according to the postprocedural survey (p=0.019). However, no difference in overall satisfaction, memory, or willingness to undergo a future endoscopy was observed between the two groups when the telephone survey was conducted on the following day. CONCLUSIONS This study demonstrated that a delayed flumazenil injection after endoscopic sedation increased patient satisfaction without prolonging recovery time, even though the benefit of the delayed flumazenil injection did not persist into the following day.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Risperidone in a child with untractable emergency delirium: a case report

A 6-year-old boy was scheduled for thoracic magnetic resonance imaging under deep sedation with midazolam 1.8 mg and propofol 100 µg/kg/min via intravenous injection. He showed emergence delirium in the post-anesthesia care unit. The staff attempted to calm him by administering flumazenil as an antidote for midazolam, propofol for further sedation, and meperidine. However, this was not successf...

متن کامل

مقــایسه اثر آرام بخشی هوشیــارانه دو داروی پروپوفول و میدازولام در اعمــال آندوسکوپی و کولونوسکوپی

Background: Endoscopic procedures are performed for diagnosis and treatment of GI disturbances and require adequate, short-time anesthesia. Propofol is a rather recently introduced IV drug used for its conscious sedation effects. This study has compared the effects and complications of propofol versus midazolam in endoscopic procedures in Hamedan in 2001. Materials and Methods: This double blin...

متن کامل

Risk factors for endoscopic sedation reversal events: a five-year retrospective study

OBJECTIVE Conscious sedation is widely used in endoscopic practice but is not without risk. We aimed to determine the frequency of sedation complications requiring reversal, and to identify potential patient and procedural risk factors. DESIGN A retrospective study of all gastrointestinal endoscopic procedures performed under conscious sedation, in a large three-campus tertiary referral endos...

متن کامل

Diagnostic utility of flumazenil in coma with suspected poisoning.

OBJECTIVE To assess the diagnostic value and safety of the benzodiazepine antagonist flumazenil in patients with coma of unclear origin with suspected poisoning. DESIGN Double blind, placebo controlled, randomised study. SETTING Intensive care unit at a major teaching hospital. PATIENTS 105 Unconscious adults admitted consecutively with suspected drug overdosage during 18 months from a to...

متن کامل

Flumazenil: A specific benzodiazepine antagonist

Flumazenil is a specific benzodiazepine (BZD) antagonist which inhibits the effects of BZD agonists by competing for the receptor site in the central nervous system. It has completed clinical trials in the United States and received final approval from the U.S. Food and Drug Administration for release in January 1992. Following intravenous injection, clinically apparent arousal usually occurs w...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 8  شماره 

صفحات  -

تاریخ انتشار 2014